The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Artificial Pancreas Devices Systems-Global Market Insights and Sales Trends 2025
Synopsis
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
The global Artificial Pancreas Devices Systems market size is expected to reach US$ 199.8 million by 2029, growing at a CAGR of 12.1% from 2023 to 2029. The market is mainly driven by the significant applications of Artificial Pancreas Devices Systems in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Artificial Pancreas Devices Systems market. Threshold Suspended Device Systems, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hybrid Closed-loop APDS segment is estimated at % CAGR for the next seven-year period.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Artificial Pancreas Devices Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Artificial Pancreas Devices Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Artificial Pancreas Devices Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Artificial Pancreas Devices Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Artificial Pancreas Devices Systems covered in this report include Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care and Defymed, etc.
The global Artificial Pancreas Devices Systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Global Artificial Pancreas Devices Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Artificial Pancreas Devices Systems market, Segment by Type:
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Global Artificial Pancreas Devices Systems market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Artificial Pancreas Devices Systems manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Artificial Pancreas Devices Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
The global Artificial Pancreas Devices Systems market size is expected to reach US$ 199.8 million by 2029, growing at a CAGR of 12.1% from 2023 to 2029. The market is mainly driven by the significant applications of Artificial Pancreas Devices Systems in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Artificial Pancreas Devices Systems market. Threshold Suspended Device Systems, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hybrid Closed-loop APDS segment is estimated at % CAGR for the next seven-year period.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Artificial Pancreas Devices Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Artificial Pancreas Devices Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Artificial Pancreas Devices Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Artificial Pancreas Devices Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Artificial Pancreas Devices Systems covered in this report include Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care and Defymed, etc.
The global Artificial Pancreas Devices Systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Global Artificial Pancreas Devices Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Artificial Pancreas Devices Systems market, Segment by Type:
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Global Artificial Pancreas Devices Systems market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Artificial Pancreas Devices Systems manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Artificial Pancreas Devices Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Artificial Pancreas Devices Systems Market Overview
1.1 Artificial Pancreas Devices Systems Product Overview
1.2 Artificial Pancreas Devices Systems Market Segment by Type
1.2.1 Threshold Suspended Device Systems
1.2.2 Hybrid Closed-loop APDS
1.2.3 Other Systems
1.3 Global Artificial Pancreas Devices Systems Market Size by Type
1.3.1 Global Artificial Pancreas Devices Systems Market Size Overview by Type (2018-2029)
1.3.2 Global Artificial Pancreas Devices Systems Historic Market Size Review by Type (2018-2023)
1.3.3 Global Artificial Pancreas Devices Systems Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Artificial Pancreas Devices Systems Sales Breakdown by Type (2018-2023)
1.4.2 Europe Artificial Pancreas Devices Systems Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Artificial Pancreas Devices Systems Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Artificial Pancreas Devices Systems Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Artificial Pancreas Devices Systems Sales Breakdown by Type (2018-2023)
2 Global Artificial Pancreas Devices Systems Market Competition by Company
2.1 Global Top Players by Artificial Pancreas Devices Systems Sales (2018-2023)
2.2 Global Top Players by Artificial Pancreas Devices Systems Revenue (2018-2023)
2.3 Global Top Players by Artificial Pancreas Devices Systems Price (2018-2023)
2.4 Global Top Manufacturers Artificial Pancreas Devices Systems Manufacturing Base Distribution, Sales Area, Product Type
2.5 Artificial Pancreas Devices Systems Market Competitive Situation and Trends
2.5.1 Artificial Pancreas Devices Systems Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Artificial Pancreas Devices Systems Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Artificial Pancreas Devices Systems as of 2022)
2.7 Date of Key Manufacturers Enter into Artificial Pancreas Devices Systems Market
2.8 Key Manufacturers Artificial Pancreas Devices Systems Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Artificial Pancreas Devices Systems Status and Outlook by Region
3.1 Global Artificial Pancreas Devices Systems Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Artificial Pancreas Devices Systems Historic Market Size by Region
3.2.1 Global Artificial Pancreas Devices Systems Sales in Volume by Region (2018-2023)
3.2.2 Global Artificial Pancreas Devices Systems Sales in Value by Region (2018-2023)
3.2.3 Global Artificial Pancreas Devices Systems Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Artificial Pancreas Devices Systems Forecasted Market Size by Region
3.3.1 Global Artificial Pancreas Devices Systems Sales in Volume by Region (2024-2029)
3.3.2 Global Artificial Pancreas Devices Systems Sales in Value by Region (2024-2029)
3.3.3 Global Artificial Pancreas Devices Systems Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Artificial Pancreas Devices Systems by Application
4.1 Artificial Pancreas Devices Systems Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.2 Global Artificial Pancreas Devices Systems Market Size by Application
4.2.1 Global Artificial Pancreas Devices Systems Market Size Overview by Application (2018-2029)
4.2.2 Global Artificial Pancreas Devices Systems Historic Market Size Review by Application (2018-2023)
4.2.3 Global Artificial Pancreas Devices Systems Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Artificial Pancreas Devices Systems Sales Breakdown by Application (2018-2023)
4.3.2 Europe Artificial Pancreas Devices Systems Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Artificial Pancreas Devices Systems Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Artificial Pancreas Devices Systems Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Artificial Pancreas Devices Systems Sales Breakdown by Application (2018-2023)
5 North America Artificial Pancreas Devices Systems by Country
5.1 North America Artificial Pancreas Devices Systems Historic Market Size by Country
5.1.1 North America Artificial Pancreas Devices Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Artificial Pancreas Devices Systems Sales in Volume by Country (2018-2023)
5.1.3 North America Artificial Pancreas Devices Systems Sales in Value by Country (2018-2023)
5.2 North America Artificial Pancreas Devices Systems Forecasted Market Size by Country
5.2.1 North America Artificial Pancreas Devices Systems Sales in Volume by Country (2024-2029)
5.2.2 North America Artificial Pancreas Devices Systems Sales in Value by Country (2024-2029)
6 Europe Artificial Pancreas Devices Systems by Country
6.1 Europe Artificial Pancreas Devices Systems Historic Market Size by Country
6.1.1 Europe Artificial Pancreas Devices Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Artificial Pancreas Devices Systems Sales in Volume by Country (2018-2023)
6.1.3 Europe Artificial Pancreas Devices Systems Sales in Value by Country (2018-2023)
6.2 Europe Artificial Pancreas Devices Systems Forecasted Market Size by Country
6.2.1 Europe Artificial Pancreas Devices Systems Sales in Volume by Country (2024-2029)
6.2.2 Europe Artificial Pancreas Devices Systems Sales in Value by Country (2024-2029)
7 Asia-Pacific Artificial Pancreas Devices Systems by Region
7.1 Asia-Pacific Artificial Pancreas Devices Systems Historic Market Size by Region
7.1.1 Asia-Pacific Artificial Pancreas Devices Systems Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Artificial Pancreas Devices Systems Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Artificial Pancreas Devices Systems Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Artificial Pancreas Devices Systems Forecasted Market Size by Region
7.2.1 Asia-Pacific Artificial Pancreas Devices Systems Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Artificial Pancreas Devices Systems Sales in Value by Region (2024-2029)
8 Latin America Artificial Pancreas Devices Systems by Country
8.1 Latin America Artificial Pancreas Devices Systems Historic Market Size by Country
8.1.1 Latin America Artificial Pancreas Devices Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Artificial Pancreas Devices Systems Sales in Volume by Country (2018-2023)
8.1.3 Latin America Artificial Pancreas Devices Systems Sales in Value by Country (2018-2023)
8.2 Latin America Artificial Pancreas Devices Systems Forecasted Market Size by Country
8.2.1 Latin America Artificial Pancreas Devices Systems Sales in Volume by Country (2024-2029)
8.2.2 Latin America Artificial Pancreas Devices Systems Sales in Value by Country (2024-2029)
9 Middle East and Africa Artificial Pancreas Devices Systems by Country
9.1 Middle East and Africa Artificial Pancreas Devices Systems Historic Market Size by Country
9.1.1 Middle East and Africa Artificial Pancreas Devices Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Artificial Pancreas Devices Systems Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Artificial Pancreas Devices Systems Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Artificial Pancreas Devices Systems Forecasted Market Size by Country
9.2.1 Middle East and Africa Artificial Pancreas Devices Systems Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Artificial Pancreas Devices Systems Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Medtronic
10.1.1 Medtronic Company Information
10.1.2 Medtronic Introduction and Business Overview
10.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Medtronic Artificial Pancreas Devices Systems Products Offered
10.1.5 Medtronic Recent Development
10.2 Bigfoot Biomedical
10.2.1 Bigfoot Biomedical Company Information
10.2.2 Bigfoot Biomedical Introduction and Business Overview
10.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bigfoot Biomedical Artificial Pancreas Devices Systems Products Offered
10.2.5 Bigfoot Biomedical Recent Development
10.3 Beta Bionics
10.3.1 Beta Bionics Company Information
10.3.2 Beta Bionics Introduction and Business Overview
10.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Beta Bionics Artificial Pancreas Devices Systems Products Offered
10.3.5 Beta Bionics Recent Development
10.4 Admetsys
10.4.1 Admetsys Company Information
10.4.2 Admetsys Introduction and Business Overview
10.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Admetsys Artificial Pancreas Devices Systems Products Offered
10.4.5 Admetsys Recent Development
10.5 Insulet
10.5.1 Insulet Company Information
10.5.2 Insulet Introduction and Business Overview
10.5.3 Insulet Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Insulet Artificial Pancreas Devices Systems Products Offered
10.5.5 Insulet Recent Development
10.6 Tandem Diabetes Care
10.6.1 Tandem Diabetes Care Company Information
10.6.2 Tandem Diabetes Care Introduction and Business Overview
10.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Products Offered
10.6.5 Tandem Diabetes Care Recent Development
10.7 Defymed
10.7.1 Defymed Company Information
10.7.2 Defymed Introduction and Business Overview
10.7.3 Defymed Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Defymed Artificial Pancreas Devices Systems Products Offered
10.7.5 Defymed Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Artificial Pancreas Devices Systems Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Artificial Pancreas Devices Systems Industrial Chain Analysis
11.4 Artificial Pancreas Devices Systems Market Dynamics
11.4.1 Artificial Pancreas Devices Systems Industry Trends
11.4.2 Artificial Pancreas Devices Systems Market Drivers
11.4.3 Artificial Pancreas Devices Systems Market Challenges
11.4.4 Artificial Pancreas Devices Systems Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Artificial Pancreas Devices Systems Distributors
12.3 Artificial Pancreas Devices Systems Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
